These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19933973)

  • 41. Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone.
    Valen-Sendstad A; Engedal K; Stray-Pedersen B; ; Strobel C; Barnett L; Meyer N; Nurminemi M
    Am J Geriatr Psychiatry; 2010 Jan; 18(1):11-20. PubMed ID: 20094015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early postmenopausal hormone therapy may prevent cognitive impairment later in life.
    Bagger YZ; Tankó LB; Alexandersen P; Qin G; Christiansen C;
    Menopause; 2005; 12(1):12-7. PubMed ID: 15668595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
    Yip AG; Brayne C; Easton D; Rubinsztein DC;
    J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.
    Williams-Gray CH; Goris A; Saiki M; Foltynie T; Compston DA; Sawcer SJ; Barker RA
    J Neurol; 2009 Mar; 256(3):493-8. PubMed ID: 19308307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.
    Mengel D; Dams J; Ziemek J; Becker J; Balzer-Geldsetzer M; Hilker R; Baudrexel S; Kalbe E; Schmidt N; Witt K; Liepelt-Scarfone I; Gräber S; Petrelli A; Neuser P; Schulte C; Linse K; Storch A; Wittchen HU; Riedel O; Mollenhauer B; Ebentheuer J; Trenkwalder C; Klockgether T; Spottke A; Wüllner U; Schulz JB; Reetz K; Heber IA; Ramirez A; Dodel R
    Parkinsonism Relat Disord; 2016 Aug; 29():112-6. PubMed ID: 27321987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Odor identification deficit as a predictor of five-year global cognitive change: interactive effects with age and ApoE-epsilon4.
    Olofsson JK; Rönnlund M; Nordin S; Nyberg L; Nilsson LG; Larsson M
    Behav Genet; 2009 Sep; 39(5):496-503. PubMed ID: 19633944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Alzheimer's related genotypes with cognitive decline in multiple domains: results from the Three-City Dijon study.
    Vivot A; Glymour MM; Tzourio C; Amouyel P; Chêne G; Dufouil C
    Mol Psychiatry; 2015 Oct; 20(10):1173-8. PubMed ID: 26033242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
    Haan MN; Shemanski L; Jagust WJ; Manolio TA; Kuller L
    JAMA; 1999 Jul; 282(1):40-6. PubMed ID: 10404910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease.
    Wroolie TE; Kenna HA; Williams KE; Rasgon NL
    Am J Geriatr Psychiatry; 2015 Nov; 23(11):1117-26. PubMed ID: 26209223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study.
    Zhu L; Fratiglioni L; Guo Z; Basun H; Corder EH; Winblad B; Viitanen M
    Stroke; 2000 Jan; 31(1):53-60. PubMed ID: 10625715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Menopause and postmenopausal hormone therapy and risk of hearing loss.
    Curhan SG; Eliassen AH; Eavey RD; Wang M; Lin BM; Curhan GC
    Menopause; 2017 Sep; 24(9):1049-1056. PubMed ID: 28486246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. APOE ε4 allele status in korean dementia patients with severe white matter hyperintensities.
    Hong YJ; Yoon B; Shim YS; Cho AH; Shin HE; Kim YI; Kim SY; Yang DW
    J Alzheimers Dis; 2011; 24(3):519-24. PubMed ID: 21297273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen receptor polymorphisms and incident dementia: the prospective 3C study.
    Ryan J; Carrière I; Carcaillon L; Dartigues JF; Auriacombe S; Rouaud O; Berr C; Ritchie K; Scarabin PY; Ancelin ML
    Alzheimers Dement; 2014 Jan; 10(1):27-35. PubMed ID: 23491264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects.
    Norberg J; Graff C; Almkvist O; Ewers M; Frisoni GB; Frölich L; Hampel H; Jones RW; Kehoe PG; Lenoir H; Minthon L; Nobili F; Olde Rikkert M; Rigaud AS; Scheltens P; Soininen H; Spiru L; Tsolaki M; Wahlund LO; Vellas B; Wilcock G; Elias-Sonnenschein LS; Verhey FR; Visser PJ
    Dement Geriatr Cogn Disord; 2011; 32(2):135-42. PubMed ID: 21952537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
    Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
    Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between ApoE epsilon4 and cognitive impairment after stroke.
    Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A gender difference in the association between APOE genotype and age-related cognitive decline.
    Mortensen EL; Høgh P
    Neurology; 2001 Jul; 57(1):89-95. PubMed ID: 11445633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postmenopausal hormone therapy and its association with cognitive impairment.
    Mitchell JL; Cruickshanks KJ; Klein BE; Palta M; Nondahl DM
    Arch Intern Med; 2003 Nov; 163(20):2485-90. PubMed ID: 14609785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.